Combo Products Would Usually Require Payment Of Only One User Fee, FDA Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Draft guidance on user fees states that the amount paid would be equivalent to one PDUFA fee when FDA requires two applications for an “innovative combination product.” FDA is developing guidance on when single or multiple applications should be submitted.